Exceptional responders, also called atypical responders, are people with cancer who have responded to treatments that are not as effective for other people. Many factors could lead to an exceptional response. Read below to learn about the need to study exceptional responders and ongoing studies that are investigating these patients.
The Need to Study Exceptional Responders and Possible Reasons for the Response
- MBC Alliance: Atypical Responders Analysis
- Journal Article: The Need to Study Atypical Responses
Ongoing Exceptional Responder Studies
- Harvard Medical School (video and article): Network of Enigmatic Exceptional Responders (NEER) Study
- Our MBC Life (podcast and article): Searching for Unicorns: Exceptional Survivors and Responders
- University of Wisconsin: Participate in the Outliers Study
Recent Results from Exceptional Responder Studies
- ASCO: How Exceptional Responders Are Providing Clues to Personalizing Cancer Treatment
- Journal Article and Graphical Abstract: Features of Cancers Exhibiting Exceptional Responses to Treatment
- University of Wisconsin: Posters About Long-Term Survivors of MBC
- SABCS Abstract: Tumor Mutational Profiles of Extreme Long-Term Survivors with Metastatic Breast Cancer
Last Modified on April 4, 2022